Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 106 to 120 of 193 results for transplantation

  1. Technology appraisal committee B members

    Find out more about the NICE technology appraisal advisory committee B members and their registered interests

  2. Voclosporin with mycophenolate mofetil for treating lupus nephritis (TA882)

    Evidence-based recommendations on voclosporin (Lupkynis) with mycophenolate mofetil for treating lupus nephritis in adults.

    Technology appraisal guidance
    Published
    3 May 2023
    View recommendations

    Sections for TA882

  3. Infliximab for acute exacerbations of ulcerative colitis (TA163)

    Evidence-based recommendations on infliximab (Remicade) for treating acute exacerbations of severely active ulcerative colitis in adults.

    Technology appraisal guidance
    Published
    17 December 2008
    View recommendations

    Sections for TA163

  4. Cystic fibrosis: diagnosis and management (NG78)

    This guideline covers diagnosing and managing cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life. There are also detailed recommendations on treating the most common infections in people with cystic fibrosis.

    NICE guideline
    Published
    25 October 2017
    View recommendations

    Sections for NG78

  5. Photochemical corneal collagen cross‑linkage using riboflavin and ultraviolet A for keratoconus and keratectasia (HTG319)

    Evidence-based recommendations on photochemical corneal cross linkage using riboflavin and ultraviolet A for keratoconus. This involves using special eye drops and exposing the eye ultraviolet light, with the aim to strengthen the cornea.

    HealthTech guidance
    Published
    25 September 2013
    View recommendations

    Sections for HTG319

  6. Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over (TA1044)

    Evidence-based recommendations on exagamglogene autotemcel (Casgevy) for treating severe sickle cell disease in people 12 years and over.

    Technology appraisal guidance
    Published
    26 February 2025
    View recommendations

    Sections for TA1044

  7. The experience of consenting for organ donation:- Does a positive experience of approach and process of consent for families increase consent rates?

    guidance details Comes from guidance Organ donation for transplantation: improving donor identification and consent rates for deceased...

    Research recommendation
    Published
    9 June 2015

  8. Improving consent rates:- What are the key components of an intervention to improve consent rates?

    guidance details Comes from guidance Organ donation for transplantation: improving donor identification and consent rates for deceased...

    Research recommendation
    Published
    9 June 2015

  9. Type 1 diabetes in adults: diagnosis and management (NG17)

    This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.

    NICE guideline
    Last updated
    17 August 2022
    View recommendations

    Sections for NG17

  10. Improving rates of identification and referral of potential donors:- What are the key components of an intervention to improve identification and referral rates?

    guidance details Comes from guidance Organ donation for transplantation: improving donor identification and consent rates for deceased...

    Research recommendation
    Published
    9 June 2015

  11. Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma (TA524)

    Evidence-based recommendations on brentuximab vedotin (Adcetris) for treating CD30-positive Hodgkin lymphoma in adults.

    Technology appraisal guidance
    Published
    13 June 2018
    View recommendations

    Sections for TA524

  12. Reasons for refusal for consent:- Why do families refuse to give permission for organ donation?

    guidance details Comes from guidance Organ donation for transplantation: improving donor identification and consent rates for deceased...

    Research recommendation
    Published
    9 June 2015

  13. Idiopathic pulmonary fibrosis in adults (QS79)

    This quality standard covers managing idiopathic pulmonary fibrosis (gradual scarring of the lungs) in adults. It includes diagnosis by a multidisciplinary team, managing symptoms and palliative care. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    29 January 2015
    View quality statements

    Sections for QS79

  14. Factors predicting outcomes for people with high-grade transformation of follicular lymphoma:- In people with high-grade transformation of follicular lymphoma, which biological and clinical factors predict good outcomes with immunochemotherapy alone?

    treatment with, for example, high-dose therapy and autologous stem cell transplantation. Many factors are likely to influence outcome,...

    Research recommendation
    Published
    25 August 2016

  15. Prophylactic treatment in people receiving immunosuppressive therapy:- Further research should be undertaken to determine whether long-term use of mild immunosuppressive agents for autoimmune and allergic problems presents a risk for reactivation of HBV infection in people with previous or current chronic hepatitis B, including occult HBV infection. The cost effectiveness of routine tests for HBV in this population, including HBV DNA for occult HBV infection, and the need for prophylactic treatment with nucleoside or nucleotide analogues needs further evaluation.

    occur spontaneously or arise during immunosuppression. Solid organ transplantation, chemotherapy and immunosuppressive drugs used to...

    Research recommendation
    Published
    9 June 2015